Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1977-11-01
1981-06-09
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, A61K 3700, C07C10352
Patent
active
042725240
ABSTRACT:
The invention relates to a new method for increasing the resistance of the organism to pathogenic germs and to compositions to carry out said method.
In this method, one administers an effective dose of N-acetyl-muramyl-L-alanyl-D-isoglutamine or analogs responding to the formula ##STR1## wherein R.sub.1 is OH or NH.sub.2, R.sub.2 is OH, NH.sub.2 or a peptidic residue containing from 1 to 6 aminoacids,
with the proviso that R.sub.1 and R.sub.2 are not simultaneously NH.sub.2.
REFERENCES:
patent: 4082735 (1978-04-01), Jones et al.
patent: 4082736 (1978-04-01), Jones et al.
F. Ellviz, et al., Biochem. and Biophys. Res. Commun., 59, 1974, pp. 1317-1325.
Ghuysen, et al., Bact. Membranes and Walls, 1973, pp. 39-41.
Chaturvedi, J. Med. Chem., 9, 1966, pp. 971-973.
Kostani, et al., Sympos. Internat'l. or Bact. Immunostimulants, 1973, p. 8.
Lamzelotti, et al., J. Am. Chem. Soc., 86, 1964.
Kotani, et al., Biken J., 13, 105-111, 1975.
Adam, et al., Biochem. and Biophys. Res. Commun., 72, 1976, pp. 339-346.
Chem. Abst., 87, 1977, pp. 199018m, 118075c, 51519e.
Chedid Louis
Choay Jean
Lederer Edgar
Lefrancier Pierre
Parant Francine
Agence Nationale de Valorisation de la Recherche (ANVAR)
Phillips Delbert R.
LandOfFree
N-Acyl-muramyl peptide derivatives having anti-infectious infect does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-Acyl-muramyl peptide derivatives having anti-infectious infect, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-Acyl-muramyl peptide derivatives having anti-infectious infect will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1263990